Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)
Clinical trial NCT02097524 · COMPLETED
Trial details
- NCT number
- NCT02097524
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-04-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.